HRX Pitch Competition: Deadline Extended to July 17, 2024

HRX Pitch Competition: Deadline Extended to July 17, 2024

Event category: Sessions

Events

September 06, 2024

2024-09-06

03:45 PM (EDT) - 04:30 PM (EDT)

Suraj Kapa | Joshua Lampert | Dan Musat | Subbu Venkatraman | Daniel Cantillon

The day-to-day practice of Cardiology has long involved use of the stethoscope, electrocardiogram and echocardiogram for assessment of patients. However, AI is completely transforming the value proposition of these "old tools", which are rapidly being transformed into disease prediction and disease identification tools. This panel will discuss the latest iterations in these "old-time" tools.

Joshua Lampert

Cardiac Electrophysiologist & Medical Director of Machine Learning

Mount Sinai Heart in The Mount Sinai Hospital

Dan Musat

Cardiac Electrophysiologist

Valley Health System

Subbu Venkatraman

Chief Technology Officer (CTO)

Eko Health

Daniel Cantillon

Adult EP Cardiologist & Chief Medical Officer

Masimo Corporation

Suraj Kapa

Cardiac Electrophysiologist

Mayo Clinic

2024-09-06

02:45 PM (EDT) - 03:45 PM (EDT)

Main Stage

Nishaki Mehta

The Top 5 scoring AbstracX Researchers will share their research.

Nishaki Mehta

Associate Professor of Medicine

William Beaumont Oakland University School of Medicine

September 05, 2024

2024-09-05

03:30 PM (EDT) - 04:30 PM (EDT)

Main Stage

Tony Fiola | Payal Cramer | Krystyna Monticello | Lynn Sessions

There has been a significant increase in the volume of data produced by patients with the litany of wearables on the market. The ability to share data between patients and providers has become easier with the advent of patient portals associated with electronic medical records. But the core question of data ownership remains—who owns these data? Data ownership is complex and important for patient empowerment. But what does the law say? Can data be co-owned by the appropriate entities involved in a patient’s care? What are the legal nuances of data ownership? And are the cybersecurity measures in place sufficient in the current state? In this session, we will start to address some of these concepts.

Payal Cramer

Counsel

Baker & Hostetler LLP

Krystyna Monticello

Attorney

Oscislawski LLC

Lynn Sessions

Partner

Baker Hostetler

Tony Fiola

Vice President & General Manager

Global Cardiac Diagnostic Services Franchise at Boston Scientific

September 07, 2024

2024-09-07

02:45 PM (EDT) - 03:30 PM (EDT)

Richard Strobridge | Paul Varosy | Dhanunjaya R. Lakkireddy | Edmondo Robinson | Jose Osorio | Rod Passman | David N. Kenigsberg

In this session, we will explore use of digital care pathways for patient education and to determine patient reported outcomes as well as institution level outcomes after interventions such as atrial fibrillation ablation

Richard Strobridge

Vice President | Former Chief Executive Officer

Commure+Athelas | Rx.Health

Paul Varosy

Director of EP | Professor of Medicine | Deputy National Program Director

VA Eastern Colorado Health Care System | University of Colorado School of Medicine | Veterans Health Administration Cardiology

Dhanunjaya R. Lakkireddy

Executive Medical Director of the Kansas City Heart Rhythm Institute

HCA Midwest in Overland Park, Kansas

Edmondo Robinson

Founder & CEO | Academic Hospitalist

Downeast Digital | Moffitt Cancer Center

Jose Osorio

Medical Director of Electrophysiology - HCA Florida Miami | Founder and CMO | Founder and President

HCA Florida Miami | 3PH Alliance | Heart Rhythm Clinical Research Solutions

David N. Kenigsberg

Clinical Cardiac Electrophysiologist & Founder

Florida Heart Rhythm Specialists and Fort Lauderdale Heart & Rhythm Surgical Center

Rod Passman

Jules Reingold Professor of Electrophysiology & Cardiac Electrophysiologist

Northwestern University Feinberg School of Medicine

2024-09-07

09:15 AM (EDT) - 10:30 AM (EDT)

Main Stage

Robert Kowal (Judge) | David Kim (Judge)

The HRX 2024 Pitch Competition provides cardiovascular startups with a platform to present their innovative products, services, and solutions to a distinguished panel of judges and potential investors and win cash prices
The top five teams selected will compete on the HRX Main Stage. Each team will have 10 minutes to creatively pitch their innovative idea, followed by five minutes to field questions from judges and attendees.

Robert Kowal

Vice President and General Manager, Cardiac Pacing Therapies | Cardiac Electrophysiologist

Medtronic

David Kim

Managing Director

digiTx Partners

September 06, 2024

2024-09-06

04:30 PM (EDT) - 05:30 PM (EDT)

Main Stage

Sana Al-Khatib | Shivani Fernando | Jennifer Jones-McMeans | Nino Isakadze | Alicia Chong Rodriguez

Cardiovascular disease is the number one killer of women. Women continue to be undertreated for cardiovascular problems compared to men, are less likely to receive bystander CPR, and are more likely to die after having a heart attack. Meanwhile, women also experience unique life events that can impact their risk, including pregnancy and menopause. The addressable market and the unmet need for cardiovascular health promotion in women is great, and yet the majority of women’s digital health funding is concentrated in maternal and reproductive health.

What are the cultural and structural barriers for developing cardiovascular digital health solutions for women? How might femtech companies increase public awareness of cardiovascular disease risk? What is the role of female representation among researchers, inventors, investors, and founders? Join incredible women leaders in tech to candidly discuss this pivotal time in women’s health innovation.

Shivani Fernando

Founder & CEO | WBJ 40 under 40 (2022)| TedX Speaker | VR, WEB Designer Developer

OxiWear

Jennifer Jones-McMeans

Divisional Vice President of Global Clinical Affair

Abbott

Nino Isakadze

Cardiac Electrophysiology Fellow

Johns Hopkins Hospital

Alicia C. Rodriguez

Founder & CEO

Bloomer Tech

Sana Al-Khatib

Professor of Medicine at Duke University | Cardiac Electrophysiologist

Duke University

2024-09-06

01:30 PM (EDT) - 02:30 PM (EDT)

Main Stage

Janet Han | Katie Adams | Caitlin Cox | Crystal Phend

Katie Adams

Senior Reporter

MedCity News

Caitlin Cox

News Editor | Associate Director of Editorial Content

TCTMD | Cardiovascular Research Foundation

Crystal Phend

Contributing Editor

MedPage Today

Janet K. Han

Associate Professor of Medicine | Cardiac Electrophysiology

UCLA | VA Greater Los Angeles Healthcare System / UCLA | Digital Health & Virtual Care

2024-09-06

09:45 AM (EDT) - 10:45 AM (EDT)

Mina K. Chung | Sumeet Chugh | Richard Price

Although a large body of research has succeeded in identifying certain patient populations at high risk for sudden cardiac arrest, the vast majority are not identified prior to the occurrence of sudden cardiac arrest.

This session will address the the next frontier for digital health - helping to overcome the challenges in identification, rapid response and treatment out of hospital cardiac arrest. Our panel will include key stakeholders: emergency and electrophysiology physicians, tech developers and researchers, those at the federal and legislative level, as well as large tech companies that will help drive a panel discussion focusing on how to drive the digital space in forward to ultimately help improve OHCA outcomes.

Sumeet Chugh

Price Endowed Professor & Associate Director, Heart Institute | Director Artificial Intelligence in Medicine

Cedars-Sinai Health System

Richard Price

Founder & President

PulsePoint Foundation

Mina K. Chung

Staff Cardiologist & Professor of Medicine in the Section of Pacing and Electrophysiology

Cleveland Clinic

September 05, 2024

2024-09-05

04:45 PM (EDT) - 05:30 PM (EDT)

Kathryn Zavala | Stephen Flaim | Giovanni Leo | Daniel Gottlieb | David Kim

Investments in cardiology devices, including digital health and AI have been in decline over the past 2 years leading many to wonder “what are investors looking for?” In this session, we will explore the current trends of investments in Cardiology, Digital Health and AI and learn from current investors who invest at all stages along the technology life cycle.

Kathryn Zavala

Chief Operating Officer

MedTech Innovator

Stephen Flaim

Senior Special Advisor & Investor-In-Residence | President | Director

National Heart Lung and Blood Institute, NIH | Flaim Partners Consulting | Haima Therapeutics

Giovanni Leo

Partner

Lake Geneva Ventures Fund at Efficient Frontier Investing

Daniel Gottlieb

Director of the MedTech Portfolio

Broadview Ventures

David Kim

Managing Director

digiTx Partners

2024-09-05

02:15 PM (EDT) - 03:00 PM (EDT)

Jacqueline Shreibati | Venk Varadan | James Colbert | Renée Arnold | Peter Noseworthy | Rod Passman | Thomas Osborne

10+ years of “point solution” pilots, and over $100B venture capital later, the digital health implementation “playbook” is being rewritten. The acceleration of generative AI in a capital-constrained environment, alongside demands for value-based care models, are changing the way we design clinical workflows, train staff, onboard patients, launch programs, and measure success. In this panel we will explore how technical advances and economic pressures are shaping the way that companies and health systems design, launch, and scale digital health solutions.

Venk Varadan

Co-founder and CEO of Nanowear

Nanowear

James Colbert

Chief Medical Officer

Memora Health

Renée Arnold

Entrepreneur-in-Residence

BioHealth Innovation, Inc. & the NIH/NHLBI

Peter Noseworthy

Professor of Medicine, Chair of the Division of Heart Rhythm Services, and Medical Director of Business Development

Mayo Clinic

Rod Passman

Jules Reingold Professor of Electrophysiology & Cardiac Electrophysiologist

Northwestern University Feinberg School of Medicine

Thomas Osborne

Chief Medical Officer

Microsoft: Federal Civilian

Jacqueline Shreibati

Cardiologist & Senior Clinical Lead

Google